Daclatasvir+Sofosbuvir Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 60+400mg
Reference Brands: Hepcinat Plus
Category: Hepatitis
This is a combination medication containing Daclatasvir 60mg and Sofosbuvir 400mg. It is used to treat chronic hepatitis C infection in adults. Hepatitis C infection is a liver disease caused by the hepatitis C virus (HCV). DACLATASVIR+SOFOSBUVIR TABLET is available in Tablets and strengths such as 60+400mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, DACLATASVIR+SOFOSBUVIR TABLET is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
DACLATASVIR+SOFOSBUVIR TABLET can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Talk to your doctor if you have liver problems other than hepatitis C infection, had a liver transplant, diabetes, heart disorders, severe kidney problems, or you are on dialysis before taking tablet.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Daclatasvir + Sofosbuvir is used for the treatment of chronic hepatitis C virus (HCV) infection, mainly genotypes 1, 3, and others as per clinical requirement. It helps reduce viral load and supports complete viral clearance when taken as a combination therapy.
It is made from the active ingredients daclatasvir, an NS5A inhibitor, and sofosbuvir, an NS5B polymerase inhibitor. Together they block viral replication and prevent the hepatitis C virus from multiplying.
Common trade names include Daklinza (daclatasvir) and Sovaldi (sofosbuvir) when sold separately. Combined generic formulations are available in India and other regions under several brand names.
Daklinza (daclatasvir) is made by Bristol-Myers Squibb, and Sovaldi (sofosbuvir) is made by Gilead Sciences. Combination generics are produced by multiple licensed manufacturers in India and other countries.
The generic name is daclatasvir + sofosbuvir.
Brand names include Daklinza (daclatasvir), Sovaldi (sofosbuvir), and various combined generic brands depending on the region.
It is manufactured by Bristol-Myers Squibb and Gilead Sciences, along with licensed generic manufacturers in India and several other global regions.
Related Products
Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir
Strength:
Ombitasvir 12.5 mg / Paritaprevir 75 mg / Ritonavir 50 mg (tablet)+ Dasabuvir 250 mg (tablet)
Form: Tablet
Reference Brands: Viekira Pak® (US); Viekirax® + Exviera® (EU)
View Details
Glecaprevir/Pibrentasvir
Strength:
Glecaprevir 100 mg Pibrentasvir 40 mg
Form: Oral tablets
Reference Brands: Mavyret®
View Details
Ribavirin
Strength:
Tablet:200 mg, 400 mg, 600mg; Capsule:200 mg; Solution:40 mg/mL
Form: Tablets, Capsules and Oral Solution
Reference Brands: Rebetol®, Copegus®, Virazole®(EU & US)
View Details
Adefovir Dipivoxil
Strength:
10 mg
Form: Oral tablets
Reference Brands: Hepsera® (EU & US)
View DetailsQuick Response Guaranteed | Verified Suppliers
